APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pertussis Vaccine

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Selected research

Industry Growth & Trends

Global Pertussis Vaccine Industry Growth and Trends Forecast to 2032

8 January 202692 pages

Choose your research edition.

Industry ResearchPertussis Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Pertussis Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Pertussis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pertussis Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pertussis Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Pertussis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pertussis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pertussis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pertussis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pertussis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pertussis Vaccine Market by Company

Sanofi Pasteur

GSK

Mitsubishi Tanabe Pharma

Wuhan Institute of Biological Products

Walvax Biotechnology

Minhai Biotechnology

KM Biologics

Chengdu Institute of Biological Products

Pertussis Vaccine Segment by Type

Whole-cell Vaccines

Acellular Vaccines

Pertussis Vaccine Segment by Application

12 Months Below

12 Months Above

Pertussis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Whole-cell Vaccines Table 2. Major Company of Acellular Vaccines Table 3. Global Pertussis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 5. Global Pertussis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pertussis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pertussis Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Pertussis Vaccine Price by Type (2021-2026) & (USD/Doses) Table 9. Global Pertussis Vaccine Sales by Type (2027-2032) & (M Doses) Table 10. Global Pertussis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pertussis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pertussis Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Pertussis Vaccine Price by Type (2027-2032) & (USD/Doses) Table 14. North America Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 15. North America Pertussis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 17. Europe Pertussis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 19. Asia-Pacific Pertussis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 21. Latin America Pertussis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 23. Middle East and Africa Pertussis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Pertussis Vaccine Industry Trends Table 25. Pertussis Vaccine Industry Drivers Table 26. Pertussis Vaccine Industry Opportunities and Challenges Table 27. Pertussis Vaccine Industry Restraints Table 28. Global Pertussis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pertussis Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Pertussis Vaccine Sales by Company (2021-2026) & (M Doses) Table 31. Global Pertussis Vaccine Sales Share by Company (2021-2026) Table 32. Global Pertussis Vaccine Market Price by Company (2021-2026) & (USD/Doses) Table 33. Global Pertussis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pertussis Vaccine Major Company Production Sites and Headquarters Table 35. Global Pertussis Vaccine Company, Product Type & Application Table 36. Global Pertussis Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pertussis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pertussis Vaccine Sales by Region (2021-2026) & (M Doses) Table 41. Global Pertussis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pertussis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pertussis Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 45. Global Pertussis Vaccine Sales by Region (2027-2032) & (M Doses) Table 46. Global Pertussis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pertussis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pertussis Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2027-2032) Table 50. Global Pertussis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 52. Global Pertussis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pertussis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pertussis Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Pertussis Vaccine Price by Application (2021-2026) & (USD/Doses) Table 56. Global Pertussis Vaccine Sales by Application (2027-2032) & (M Doses) Table 57. Global Pertussis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pertussis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pertussis Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Pertussis Vaccine Price by Application (2027-2032) & (USD/Doses) Table 61. North America Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 62. North America Pertussis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 64. Europe Pertussis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 66. Asia-Pacific Pertussis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 68. Latin America Pertussis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 70. Middle East and Africa Pertussis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Pasteur Company Information Table 72. Sanofi Pasteur Business Overview Table 73. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 74. Sanofi Pasteur Pertussis Vaccine Product Portfolio Table 75. Sanofi Pasteur Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 79. GSK Pertussis Vaccine Product Portfolio Table 80. GSK Recent Development Table 81. Mitsubishi Tanabe Pharma Company Information Table 82. Mitsubishi Tanabe Pharma Business Overview Table 83. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 84. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio Table 85. Mitsubishi Tanabe Pharma Recent Development Table 86. Wuhan Institute of Biological Products Company Information Table 87. Wuhan Institute of Biological Products Business Overview Table 88. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 89. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio Table 90. Wuhan Institute of Biological Products Recent Development Table 91. Walvax Biotechnology Company Information Table 92. Walvax Biotechnology Business Overview Table 93. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 94. Walvax Biotechnology Pertussis Vaccine Product Portfolio Table 95. Walvax Biotechnology Recent Development Table 96. Minhai Biotechnology Company Information Table 97. Minhai Biotechnology Business Overview Table 98. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 99. Minhai Biotechnology Pertussis Vaccine Product Portfolio Table 100. Minhai Biotechnology Recent Development Table 101. KM Biologics Company Information Table 102. KM Biologics Business Overview Table 103. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 104. KM Biologics Pertussis Vaccine Product Portfolio Table 105. KM Biologics Recent Development Table 106. Chengdu Institute of Biological Products Company Information Table 107. Chengdu Institute of Biological Products Business Overview Table 108. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 109. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio Table 110. Chengdu Institute of Biological Products Recent Development Table 111. North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 112. North America Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 113. North America Pertussis Vaccine Sales Market Share by Country (2021-2026) Table 114. North America Pertussis Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 115. North America Pertussis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 116. North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Pertussis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Pertussis Vaccine Market Share by Country (2021-2026) Table 119. North America Pertussis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Pertussis Vaccine Market Share Forecast by Country (2027-2032) Table 121. Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 122. Europe Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 123. Europe Pertussis Vaccine Sales Market Share by Country (2021-2026) Table 124. Europe Pertussis Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 125. Europe Pertussis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Pertussis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Pertussis Vaccine Market Share by Country (2021-2026) Table 129. Europe Pertussis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Pertussis Vaccine Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 133. Asia-Pacific Pertussis Vaccine Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Pertussis Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 135. Asia-Pacific Pertussis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Pertussis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Pertussis Vaccine Market Share by Country (2021-2026) Table 139. Asia-Pacific Pertussis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Pertussis Vaccine Market Share Forecast by Country (2027-2032) Table 141. Latin America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 142. Latin America Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 143. Latin America Pertussis Vaccine Sales Market Share by Country (2021-2026) Table 144. Latin America Pertussis Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 145. Latin America Pertussis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Pertussis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Pertussis Vaccine Market Share by Country (2021-2026) Table 149. Latin America Pertussis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Pertussis Vaccine Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 153. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Pertussis Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 155. Middle East and Africa Pertussis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Pertussis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Pertussis Vaccine Market Share by Country (2021-2026) Table 159. Middle East and Africa Pertussis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Pertussis Vaccine Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Pertussis Vaccine Distributors List Table 164. Pertussis Vaccine Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Pertussis Vaccine Image Figure 2. Global Pertussis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pertussis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pertussis Vaccine Sales (2021-2032) & (M Doses) Figure 5. Whole-cell Vaccines Image Figure 6. Global Whole-cell Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Acellular Vaccines Image Figure 8. Global Acellular Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Global Pertussis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pertussis Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Pertussis Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Pertussis Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Pertussis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pertussis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pertussis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pertussis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pertussis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pertussis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pertussis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pertussis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. 12 Months Below Image Figure 24. Global 12 Months Below Sales YoY Growth (2021-2032) & (M Doses) Figure 25. 12 Months Above Image Figure 26. Global 12 Months Above Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Global Pertussis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Pertussis Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Pertussis Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Pertussis Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Pertussis Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Pertussis Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Pertussis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Pertussis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Pertussis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Pertussis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Pertussis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Pertussis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Pertussis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 40. North America Pertussis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Pertussis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Pertussis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Pertussis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 44. Europe Pertussis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pertussis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Pertussis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Pertussis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 48. Asia-Pacific Pertussis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pertussis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Pertussis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Pertussis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 52. Latin America Pertussis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pertussis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Pertussis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Pertussis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 56. Middle East and Africa Pertussis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pertussis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Pertussis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Pertussis Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Pertussis Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Whole-cell Vaccines
  • Acellular Vaccines
Applications
  • 12 Months Below
  • 12 Months Above
Companies covered
  • Sanofi Pasteur
  • GSK
  • Mitsubishi Tanabe Pharma
  • Wuhan Institute of Biological Products
  • Walvax Biotechnology
  • Minhai Biotechnology
  • KM Biologics
  • Chengdu Institute of Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pertussis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pertussis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pertussis Vaccine Market by Type
  6. 1.3.1 Whole-cell Vaccines
  7. 1.3.2 Acellular Vaccines
  8. 1.4 Global Pertussis Vaccine Market Size by Type
  9. 1.4.1 Global Pertussis Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pertussis Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pertussis Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pertussis Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pertussis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pertussis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pertussis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pertussis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pertussis Vaccine Industry Trends
  2. 2.2 Pertussis Vaccine Industry Drivers
  3. 2.3 Pertussis Vaccine Industry Opportunities and Challenges
  4. 2.4 Pertussis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pertussis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Pertussis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Pertussis Vaccine Price (2021-2026)
  4. 3.4 Global Pertussis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pertussis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Pertussis Vaccine Company, Product Type & Application
  7. 3.7 Global Pertussis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pertussis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pertussis Vaccine Tier 1, Tier 2, and Tier 3
4 Pertussis Vaccine Regional Status and Outlook
  1. 4.1 Global Pertussis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pertussis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Pertussis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pertussis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pertussis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pertussis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Pertussis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pertussis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pertussis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pertussis Vaccine by Application
  1. 5.1 Pertussis Vaccine Market by Application
  2. 5.1.1 12 Months Below
  3. 5.1.2 12 Months Above
  4. 5.2 Global Pertussis Vaccine Market Size by Application
  5. 5.2.1 Global Pertussis Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Pertussis Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Pertussis Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Pertussis Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Pertussis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Pertussis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Pertussis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Pertussis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi Pasteur
  2. 6.1.1 Sanofi Pasteur Company Information
  3. 6.1.2 Sanofi Pasteur Business Overview
  4. 6.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
  6. 6.1.5 Sanofi Pasteur Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Pertussis Vaccine Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Mitsubishi Tanabe Pharma
  14. 6.3.1 Mitsubishi Tanabe Pharma Company Information
  15. 6.3.2 Mitsubishi Tanabe Pharma Business Overview
  16. 6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
  18. 6.3.5 Mitsubishi Tanabe Pharma Recent Developments
  19. 6.4 Wuhan Institute of Biological Products
  20. 6.4.1 Wuhan Institute of Biological Products Company Information
  21. 6.4.2 Wuhan Institute of Biological Products Business Overview
  22. 6.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
  24. 6.4.5 Wuhan Institute of Biological Products Recent Developments
  25. 6.5 Walvax Biotechnology
  26. 6.5.1 Walvax Biotechnology Company Information
  27. 6.5.2 Walvax Biotechnology Business Overview
  28. 6.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
  30. 6.5.5 Walvax Biotechnology Recent Developments
  31. 6.6 Minhai Biotechnology
  32. 6.6.1 Minhai Biotechnology Company Information
  33. 6.6.2 Minhai Biotechnology Business Overview
  34. 6.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
  36. 6.6.5 Minhai Biotechnology Recent Developments
  37. 6.7 KM Biologics
  38. 6.7.1 KM Biologics Company Information
  39. 6.7.2 KM Biologics Business Overview
  40. 6.7.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 KM Biologics Pertussis Vaccine Product Portfolio
  42. 6.7.5 KM Biologics Recent Developments
  43. 6.8 Chengdu Institute of Biological Products
  44. 6.8.1 Chengdu Institute of Biological Products Company Information
  45. 6.8.2 Chengdu Institute of Biological Products Business Overview
  46. 6.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
  48. 6.8.5 Chengdu Institute of Biological Products Recent Developments
7 North America by Country
  1. 7.1 North America Pertussis Vaccine Sales by Country
  2. 7.1.1 North America Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pertussis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Pertussis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pertussis Vaccine Market Size by Country
  6. 7.2.1 North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pertussis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Pertussis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pertussis Vaccine Sales by Country
  2. 8.1.1 Europe Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pertussis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Pertussis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pertussis Vaccine Market Size by Country
  6. 8.2.1 Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pertussis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pertussis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pertussis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pertussis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pertussis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pertussis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pertussis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pertussis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pertussis Vaccine Sales by Country
  2. 10.1.1 South America Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pertussis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Pertussis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pertussis Vaccine Market Size by Country
  6. 10.2.1 South America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pertussis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Pertussis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pertussis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pertussis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pertussis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pertussis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pertussis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pertussis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pertussis Vaccine Value Chain Analysis
  2. 12.1.1 Pertussis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pertussis Vaccine Production Mode & Process
  7. 12.2 Pertussis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pertussis Vaccine Distributors
  10. 12.2.3 Pertussis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst